Regulation of Innate Responses during Pre-patent Schistosome Infection Provides an Immune Environment Permissive for Parasite Development

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Riner, Diana K ^a   Ferragine, Christine E ^a   Maynard, Sean K ^a   Davies, Stephen J ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; INTERLEUKIN 4; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEPATITIS; INNATE IMMUNITY; MALE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, NEUTRALIZING; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-4; MICE; MICE, KNOCKOUT; SCHISTOSOMA; SCHISTOSOMIASIS; TH2 CELLS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887295649     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003708     Document Type: Article

References (71)

1. Davies SJ, Grogan JL, Blank RB, Lim KC, Locksley RM, et al. (2001) Modulation of Blood Fluke Development in the Liver by Hepatic CD4+ Lymphocytes. Science 294: 1358-1361.
2. Lamb EW, Crow ET, Lim KC, Liang YS, Lewis FA, et al. (2007) Conservation of CD4+ T cell-dependent developmental mechanisms in the blood fluke pathogens of humans. Int J Parasitol 37: 405-415.
3. Harrison RA, Doenhoff MJ, (1983) Retarded development of Schistosoma mansoni in immunosuppressed mice. Parasitology 86: 429-438.
4. Lamb EW, Walls CD, Pesce JT, Riner DK, Maynard SK, et al. (2010) Blood fluke exploitation of non-cognate CD4+ T cell help to facilitate parasite development. PLoS Pathog 6: e1000892.
5. Stadecker MJ, Asahi H, Finger E, Hernandez HJ, Rutitzky LI, et al. (2004) The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol Rev 201: 168-179.
6. Pearce EJ, MacDonald AS, (2002) The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499-511.
7. Pearce EJ, C MK, Sun J, J JT, McKee AS, et al. (2004) Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev 201: 117-126.
8. Brunet LR, Finkelman FD, Cheever AW, Kopf MA, Pearce EJ, (1997) IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J Immunol 159: 777-785.
9. Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN, (2000) Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 164: 2585-2591.
10. de Oliveira Fraga LA, Torrero MN, Tocheva AS, Mitre E, Davies SJ, (2010) Induction of type 2 responses by schistosome worms during prepatent infection. J Infect Dis 201: 464-472.
11. de Oliveira Fraga LA, Lamb EW, Moreno EC, Chatterjee M, Dvorak J, et al. (2010) Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection. BMC Immunol 11: 56.
12. Leptak CL, McKerrow JH, (1997) Schistosome egg granulomas and hepatic expression of TNF-alpha are dependent on immune priming during parasite maturation. J Immunol 158: 301-307.
13. Patton EA, Brunet LR, La Flamme AC, Pedras-Vasconcelos J, Kopf M, et al. (2001) Severe schistosomiasis in the absence of interleukin-4 (IL-4) is IL-12 independent. Infect Immun 69: 589-592.
14. Hoffmann KF, Cheever AW, Wynn TA, (2000) IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164: 6406-6416.
15. Jankovic D, Kullberg MC, Noben-Trauth N, Caspar P, Ward JM, et al. (1999) Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J Immunol 163: 337-342.
16. Meleney HE, Moore DV, Most H, Carney BH, (1953) The histopathology of experimental schistosomiasis. I. The hepatic lesions in mice infected with S. mansoni, S. japonicum and S. haematobium. Am J Trop Med Hyg 1: 263-285.
17. Page CR, (1971) Experimental prepatent schistosomiasis mansoni: host mortality and pathology. Am J Trop Med Hyg 20: 894-903.
18. Chen GY, Tang J, Zheng P, Liu Y, (2009) CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323: 1722-1725.
19. Chung H, Kim HJ, Jang KS, Kim M, Yang J, et al. (2006) Comprehensive analysis of differential gene expression profiles on D-galactosamine-induced acute mouse liver injury and regeneration. Toxicology 227: 136-144.
20. McCuskey RS, Bethea NW, Wong J, McCuskey MK, Abril ER, et al. (2005) Ethanol binging exacerbates sinusoidal endothelial and parenchymal injury elicited by acetaminophen. J Hepatol 42: 371-377.
21. Keppler D, Lesch R, Reutter W, Decker K, (1968) Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 9: 279-290.
22. Shi Y, Evans JE, Rock KL, (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521.
23. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J, (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
24. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA, (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126.
25. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856.
26. Martinon F, Mayor A, Tschopp J, (2009) The Inflammasomes: Guardians of the Body. Annual Review of Immunology 27: 229-265.
27. Aldridge JR Jr, Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, et al. (2009) TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A 106: 5306-5311.
28. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, et al. (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100: 2552-2561.
29. Szymczak WA, Deepe GS Jr, (2009) The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity. J Immunol 183: 1964-1974.
30. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA, (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
31. Fong Y, Moldawer LL, Marano M, Wei H, Barber A, et al. (1989) Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 256: R659-665.
32. Butler DM, Maini RN, Feldmann M, Brennan FM, (1995) Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw 6: 225-230.
33. Woods JM, Katschke KJ, Volin MV, Ruth JH, Woodruff DC, et al. (2001) IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J Immunol 166: 1214-1222.
34. Cao Y, Brombacher F, Tunyogi-Csapo M, Glant TT, Finnegan A, (2007) Interleukin-4 regulates proteoglycan-induced arthritis by specifically suppressing the innate immune response. Arthritis Rheum 56: 861-870.
35. te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG, (1990) Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood 76: 1392-1397.
36. Raes G, De Baetselier P, Noel W, Beschin A, Brombacher F, et al. (2002) Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J Leukoc Biol 71: 597-602.
37. McNally AK, Anderson JM, (1995) Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 147: 1487-1499.
38. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, et al. (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2: 223-238.
39. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, et al. (2004) Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623-635.
40. Dunne DW, Pearce EJ, (1999) Immunology of hepatosplenic schistosomiasis mansoni: a human perspective. Microbes Infect 1: 553-560.
41. Doenhoff M, Musallam R, Bain J, McGregor A, (1978) Studies on the host-parasite relationship in Schistosoma mansoni- infected mice: the immunological dependence of parasite egg excretion. Immunology 35: 771-778.
42. Bianchi ME, (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5.
43. Biswas SK, Lopez-Collazo E, (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30: 475-487.
44. Kono H, Chen CJ, Ontiveros F, Rock KL, (2010) Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest 120: 1939-1949.
45. Laskin DL, (2009) Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol 22: 1376-1385.
46. Holt MP, Cheng L, Ju C, (2008) Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol 84: 1410-1421.
47. Kuroda E, Ishii Ken J, Uematsu S, Ohata K, Coban C, et al. (2011) Silica Crystals and Aluminum Salts Regulate the Production of Prostaglandin in Macrophages via NALP3 Inflammasome-Independent Mechanisms. Immunity 34: 514-526.
48. Kool M, Willart Monique AM, van Nimwegen M, Bergen I, Pouliot P, et al. (2011) An Unexpected Role for Uric Acid as an Inducer of T Helper 2 Cell Immunity to Inhaled Antigens and Inflammatory Mediator of Allergic Asthma. Immunity 34: 527-540.
49. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, et al. (2009) Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor B. Proceedings of the National Academy of Sciences 106: 14978-14983.
50. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643.
51. Baeten D, Kruithof E, Van den Bosch F, Demetter P, Van Damme N, et al. (2001) Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 44: 186-195.
52. Smeets TJ, Kraan MC, van Loon ME, Tak PP, (2003) Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis Rheum 48: 2155-2162.
53. De Rycke L, Baeten D, Foell D, Kruithof E, Veys EM, et al. (2005) Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. J Pathol 206: 17-27.
54. Martin WJ, Shaw O, Liu X, Steiger S, Harper JL, (2011) MSU crystal-recruited non-inflammatory monocytes differentiate into M1-like pro-inflammatory macrophages in a peritoneal murine model of gout. Arthritis Rheum E-pub ahead of print. doi: 10.1002/art.30245.
55. Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, et al. (2004) Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 50: 2273-2280.
56. Allen JE, Wynn TA, (2011) Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog 7: e1002003.
57. Reece JJ, Siracusa MC, Scott AL, (2006) Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophages. Infect Immun 74: 4970-4981.
58. Chen F, Liu Z, Wu W, Rozo C, Bowdridge S, et al. (2012) An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med 18: 260-266.
59. Mishra BB, Gundra UM, Teale JM, (2011) STAT6(-)/(-) mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis. J Neuroimmunol 232: 26-34.
60. Gundra UM, Mishra BB, Wong K, Teale JM, (2011) Increased disease severity of parasite-infected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis. Infect Immun 79: 2586-2596.
61. Cook PC, Aynsley SA, Turner JD, Jenkins GR, Van Rooijen N, et al. (2011) Multiple helminth infection of the skin causes lymphocyte hypo-responsiveness mediated by Th2 conditioning of dermal myeloid cells. PLoS Pathog 7: e1001323.
62. Weinkopff T, Lammie P, (2011) Lack of evidence for the direct activation of endothelial cells by adult female and microfilarial excretory-secretory products. PLoS One 6: e22282.
63. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, et al. (2009) The genome of the blood fluke Schistosoma mansoni. Nature 460: 352-358.
64. Wen H, Ting JP, O'Neill LA, (2012) A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation? Nat Immunol 13: 352-357.
65. Babayan SA, Read AF, Lawrence RA, Bain O, Allen JE, (2010) Filarial parasites develop faster and reproduce earlier in response to host immune effectors that determine filarial life expectancy. PLoS Biol 8: e1000525.
66. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, et al. (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
67. Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, et al. (1997) Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 159: 3364-3371.
68. Hernandez DC, Lim KC, McKerrow JH, Davies SJ, (2004) Schistosoma mansoni: sex-specific modulation of parasite growth by host immune signals. Exp Parasitol 106: 59-61.
69. Blank RB, Lamb EW, Tocheva AS, Crow ET, Lim KC, et al. (2006) The common gamma chain cytokines interleukin (IL)-2 and IL-7 indirectly modulate blood fluke development via effects on CD4+ T cells. J Infect Dis 194: 1609-1616.
70. Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, et al. (2011) Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of TH2 Inflammation. Science 332: 1284-1288.
71. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.